Utility of Serum Fatty Acid Concentrations as a Marker for Acute Myocardial Infarction and Their Potential Role in the Formation of IschemiaModified Albumin: A Pilot Study

To the Editor:
Myocardial ischemia, which precedes acute myocardial infarction (AMI) 1 is associated with changes in human serum albumin (HSA) that result in decreased divalent cobalt ion (Co 2ϩ ) binding. This reaction the basis of the serum colorimetric Co 2ϩ -HSA binding assay, which is an indirect measure of ischemia-modified albumin (IMA).
Previously we showed that IMA was a useful diagnostic test for the diagnosis of myocardial ischemia in suspected acute coronary syndromes (ACS) patients (area under the ROC curve 0.95) (1 ) . The IMA values are reversible between ischemic and nonischemic conditions (2 ) . Furthermore, it is known that HSA is the primary binder of fatty acids, commonly known as free fatty acids (FFA), and that plasma concentrations of FFAs are increased during myocardial ischemia owing to a compensatory hyperadrenergic state. Considering these findings, we explored the hypothesis that FFAinduced conformational perturbations of HSA are the basis of the IMA test, and FFAs may themselves serve as a potential marker(s) of myocardial injury.
Using pooled serum specimens, we performed an in vitro study to test the effect of physiolog- ; or with serum albumin of Ͻ30 g/L and Ͼ55 g/L were excluded from this study. The AMI group comprised 15 males and 19 females, and their mean age was 64.5 years. The non-AMI group consisted of 10 males and 14 females with a mean age of 62.8 years. We measured serum FFA concentrations by using a colorimetric nonesterified fatty acid determination kit (Wako Chemicals) and measured IMA values by using reagents and standards provided by Inverness Medical. We also quantified specific serum FFA concentrations in non-AMI and AMI individuals (n ϭ 13 per group) by using organic solvent extraction, thin-layer chromatography, transesterification, and capillary-zone electrophoresis (3 ) . All values are expressed as mean Ϯ2 SD. Statistical significance was assessed by Wilcoxon tests and P values Ͻ0.05 were considered significant.
In the in vitro studies performed using pooled sera, addition of fatty acids showed elevations in IMA values. Oleate and arachidonate additions at a comparable fatty acid/HSA molar ratio of about 8 produced a significant increase in the percentage IMA values by 32.3 Ϯ 0.8 and 37.9 Ϯ 0.5, respectively. Serum FFA concentrations of persons with and without AMI were 1.03 Ϯ 0.45 mmol/L and 0.77 Ϯ 0.34 mmol/L, respectively (P Ͻ 0.018), and in the same 2 groups the IMA values were 119.4 Ϯ 37.3 U/mL and 88.6 Ϯ 19.3 U/mL, respectively (P Ͻ 0.0005). The ratios of mean values of FFA (1.34) and IMA (1.35) for AMI and non-AMI individuals are virtually identical, suggesting a temporal and proportional relationship. The correlation coefficient between FFA and IMA values in our test patients was 0.3293 (P ϭ 0.012), indicating a statistically significant positive relationship. In the analysis of individual FFAs, 5 fatty acids, oleic, palmitic, linoleic, stearic, and palmitoleic acid, showed statistically significant elevations in AMI patients compared to non-AMI individuals (Table 1) . Several potential cardiac markers for the diagnosis of ACS syndrome continue to be investigated (4 
